Management of anaesthesia for patients undergoing mucormycosis surgery
Not Applicable
- Conditions
- Health Condition 1: U072- COVID 19 virus not identified
- Registration Number
- CTRI/2021/09/036211
- Lead Sponsor
- Supreeth R Shetty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients requiring anaesthesia for debridement of rhinocerebral mucormycosis.
2.Patients willing to participate.
Exclusion Criteria
1.Patient refusal
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO assess mortality and morbidity like need for ICU stay, mechanical ventilation after surgeryTimepoint: 0 hours after extubation <br/ ><br>24 hours after end of surgery
- Secondary Outcome Measures
Name Time Method difficulty in airway management, blood loss, blood transfusion requirement, surgical complications, airway complications.Timepoint: upto 24 hours postoperatively